Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gravina

Showing results (751-760 of 1,077) with videos related to

Pageof 108
Sort By:
Clinical Therapeutics|July 25, 2006
Effects of 1 year of treatment with pioglitazone or rosiglitazone added to glimepiride on lipoprotein (a) and homocysteine concentrations in patients with type 2 diabetes mellitus and metabolic syndrome: a multicenter, randomized, double-blind, controlled clinical trialGiuseppe Derosa, Arrigo F G Cicero, Angela D'Angelo, et al.
Journal of Hematology & Oncology|March 16, 2018
Correction to: The first-in-class alkylating deacetylase inhibitor molecule tinostamustine shows antitumor effects and is synergistic with radiotherapy in preclinical models of glioblastomaC Festuccia, A Mancini, A Colapietro, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|June 23, 2017
The novel CXCR4 antagonist, PRX177561, reduces tumor cell proliferation and accelerates cancer stem cell differentiation in glioblastoma preclinical modelsGiovanni Luca Gravina, Andrea Mancini, Alessandro Colapietro, et al.
Cancer Cytopathology|May 29, 2019
A large series of hyalinizing trabecular tumors: Cytomorphology and ancillary techniques on fine needle aspirationMarco Dell'Aquila, Carmen Gravina, Alessandra Cocomazzi, et al.
Journal of Hematology & Oncology|March 1, 2018
The first-in-class alkylating deacetylase inhibitor molecule tinostamustine shows antitumor effects and is synergistic with radiotherapy in preclinical models of glioblastomaClaudio Festuccia, Andrea Mancini, Alessandro Colapietro, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|March 10, 2007
Telmisartan and irbesartan therapy in type 2 diabetic patients treated with rosiglitazone: effects on insulin-resistance, leptin and tumor necrosis factor-alphaGiuseppe Derosa, Arrigo F G Cicero, Angela D'Angelo, et al.
Scientific Reports|April 15, 2020
Massive bioconstructions built by Neopycnodonte cochlear (Mollusca, Bivalvia) in a mesophotic environment in the central Mediterranean SeaFrine Cardone, Giuseppe Corriero, Caterina Longo, et al.
Cancers|October 24, 2019
The Brain Penetrating and Dual TORC1/TORC2 Inhibitor, RES529, Elicits Anti-Glioma Activity and Enhances the Therapeutic Effects of Anti-Angiogenetic Compounds in Preclinical Murine ModelsGiovanni Luca Gravina, Andrea Mancini, Alessandro Colapietro, et al.
Autoimmunity Reviews|June 1, 2017
Survivin in autoimmune diseasesG Gravina, C Wasén, M J Garcia-Bonete, et al.
Journal of Alzheimer'S Disease : JAD|July 5, 2008
The RELN locus in Alzheimer's diseaseDavide Seripa, Maria Giovanna Matera, Marilisa Franceschi, et al.
Pageof 108

Showing results (751-760 of 1,077) with videos related to

Sort By:
Pageof 108
Clinical Therapeutics|July 25, 2006
Effects of 1 year of treatment with pioglitazone or rosiglitazone added to glimepiride on lipoprotein (a) and homocysteine concentrations in patients with type 2 diabetes mellitus and metabolic syndrome: a multicenter, randomized, double-blind, controlled clinical trialGiuseppe Derosa, Arrigo F G Cicero, Angela D'Angelo, et al.
Journal of Hematology & Oncology|March 16, 2018
Correction to: The first-in-class alkylating deacetylase inhibitor molecule tinostamustine shows antitumor effects and is synergistic with radiotherapy in preclinical models of glioblastomaC Festuccia, A Mancini, A Colapietro, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|June 23, 2017
The novel CXCR4 antagonist, PRX177561, reduces tumor cell proliferation and accelerates cancer stem cell differentiation in glioblastoma preclinical modelsGiovanni Luca Gravina, Andrea Mancini, Alessandro Colapietro, et al.
Cancer Cytopathology|May 29, 2019
A large series of hyalinizing trabecular tumors: Cytomorphology and ancillary techniques on fine needle aspirationMarco Dell'Aquila, Carmen Gravina, Alessandra Cocomazzi, et al.
Journal of Hematology & Oncology|March 1, 2018
The first-in-class alkylating deacetylase inhibitor molecule tinostamustine shows antitumor effects and is synergistic with radiotherapy in preclinical models of glioblastomaClaudio Festuccia, Andrea Mancini, Alessandro Colapietro, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|March 10, 2007
Telmisartan and irbesartan therapy in type 2 diabetic patients treated with rosiglitazone: effects on insulin-resistance, leptin and tumor necrosis factor-alphaGiuseppe Derosa, Arrigo F G Cicero, Angela D'Angelo, et al.
Scientific Reports|April 15, 2020
Massive bioconstructions built by Neopycnodonte cochlear (Mollusca, Bivalvia) in a mesophotic environment in the central Mediterranean SeaFrine Cardone, Giuseppe Corriero, Caterina Longo, et al.
Cancers|October 24, 2019
The Brain Penetrating and Dual TORC1/TORC2 Inhibitor, RES529, Elicits Anti-Glioma Activity and Enhances the Therapeutic Effects of Anti-Angiogenetic Compounds in Preclinical Murine ModelsGiovanni Luca Gravina, Andrea Mancini, Alessandro Colapietro, et al.
Autoimmunity Reviews|June 1, 2017
Survivin in autoimmune diseasesG Gravina, C Wasén, M J Garcia-Bonete, et al.
Journal of Alzheimer'S Disease : JAD|July 5, 2008
The RELN locus in Alzheimer's diseaseDavide Seripa, Maria Giovanna Matera, Marilisa Franceschi, et al.
Pageof 108